Abnormal Pap Test While Pregnant
Pregnancy does not seem to increase the progression of abnormal cervical cell changes. The presence of abnormal cervical cell changes or HPV does not affect the outcome of the pregnancy. Close monitoring is needed so that you and your health professional can make the best treatment decisions at each stage of the pregnancy.
If colposcopy shows normal tissue, then a repeat Pap test or colposcopy may be done later. Having a second test depends on the type of abnormalities reported on the first Pap test.
If colposcopy confirms abnormal tissue areas, a cervical biopsy may be done to diagnose the abnormal tissue. This level of testing is also done to make sure cervical cancer, which is rare, is not present. If a cervical biopsy is needed during pregnancy, it does not usually cause problems with the pregnancy, though the risk of bleeding is greater after the first trimester. Minor cell changes should continue to be monitored during the pregnancy and after delivery. Many minor cell changes return to normal after delivery.
Moderate to severe cell changes shown on an abnormal Pap test are always evaluated by colposcopy, and possibly cervical biopsy, to diagnose the abnormal tissue and to make sure invasive cervical cancer is not present. Follow-up Pap tests and colposcopy may be done for the rest of the pregnancy to monitor the progression of the cell changes. Moderate to severe changes can be monitored closely, and treatment can wait until after delivery. In rare cases, a procedure called a cone biopsy is needed to rule out cancer.
Invasive cervical cancer must be treated as soon as possible. It is harder to manage because of the concern for the outcome of both the woman and her pregnancy. Treatment will be managed by a team of health professionals who specialize in cancer and high-risk pregnancies.
To learn more about Healthwise, visit Healthwise.org.
© 1995-2020 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.